CN203083994U - 一种过滤检测技术装置 - Google Patents
一种过滤检测技术装置 Download PDFInfo
- Publication number
- CN203083994U CN203083994U CN 201220626863 CN201220626863U CN203083994U CN 203083994 U CN203083994 U CN 203083994U CN 201220626863 CN201220626863 CN 201220626863 CN 201220626863 U CN201220626863 U CN 201220626863U CN 203083994 U CN203083994 U CN 203083994U
- Authority
- CN
- China
- Prior art keywords
- detection
- filtrator
- detection technique
- checked
- technique device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 93
- 238000001914 filtration Methods 0.000 title claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 42
- 239000007790 solid phase Substances 0.000 claims abstract description 14
- 238000004458 analytical method Methods 0.000 claims abstract description 8
- 239000012071 phase Substances 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 239000000427 antigen Substances 0.000 claims description 29
- 102000036639 antigens Human genes 0.000 claims description 29
- 108091007433 antigens Proteins 0.000 claims description 29
- 239000002245 particle Substances 0.000 claims description 15
- 238000003745 diagnosis Methods 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 238000005220 pharmaceutical analysis Methods 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 2
- 238000011161 development Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229940106780 human fibrinogen Drugs 0.000 description 63
- 239000000243 solution Substances 0.000 description 36
- 238000005516 engineering process Methods 0.000 description 34
- 238000002474 experimental method Methods 0.000 description 20
- 239000012530 fluid Substances 0.000 description 19
- 239000006249 magnetic particle Substances 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 238000013016 damping Methods 0.000 description 12
- 238000010790 dilution Methods 0.000 description 12
- 239000012895 dilution Substances 0.000 description 12
- 238000002038 chemiluminescence detection Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 9
- 102000008946 Fibrinogen Human genes 0.000 description 8
- 108010049003 Fibrinogen Proteins 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000000274 adsorptive effect Effects 0.000 description 8
- 239000011543 agarose gel Substances 0.000 description 8
- 229940012952 fibrinogen Drugs 0.000 description 8
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- KQDJTBPASNJQFQ-UHFFFAOYSA-N 2-iodophenol Chemical compound OC1=CC=CC=C1I KQDJTBPASNJQFQ-UHFFFAOYSA-N 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 5
- 239000003547 immunosorbent Substances 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- -1 urea peroxides Chemical class 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 239000007863 gel particle Substances 0.000 description 4
- 238000002523 gelfiltration Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 2
- RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000003901 oxalic acid esters Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical class C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201220626863 CN203083994U (zh) | 2012-11-25 | 2012-11-25 | 一种过滤检测技术装置 |
PCT/CN2013/001433 WO2014079152A1 (zh) | 2012-11-25 | 2013-11-22 | 一种过滤检测装置及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201220626863 CN203083994U (zh) | 2012-11-25 | 2012-11-25 | 一种过滤检测技术装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN203083994U true CN203083994U (zh) | 2013-07-24 |
Family
ID=48829819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201220626863 Expired - Lifetime CN203083994U (zh) | 2012-11-25 | 2012-11-25 | 一种过滤检测技术装置 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN203083994U (zh) |
WO (1) | WO2014079152A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014079152A1 (zh) * | 2012-11-25 | 2014-05-30 | 北京康华源科技发展有限公司 | 一种过滤检测装置及其应用 |
CN103869061A (zh) * | 2012-11-25 | 2014-06-18 | 常州博闻迪医药科技有限公司 | 一种过滤检测技术装置及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3925017A (en) * | 1973-05-01 | 1975-12-09 | Wisconsin Alumni Res Found | Preparation of dry, porous gel particles having high water regain for liquid sampling |
JP2975747B2 (ja) * | 1991-11-25 | 1999-11-10 | 松下電器産業株式会社 | 免疫的検出方法 |
US8501115B2 (en) * | 2008-10-24 | 2013-08-06 | Statspin, Inc. | Modular system for performing laboratory protocols and associated methods |
JP2012018039A (ja) * | 2010-07-07 | 2012-01-26 | Sony Corp | マイクロ流路と核酸ハイブリダイゼーションのためのマイクロチップとカラム及び装置並びに方法 |
CN203083994U (zh) * | 2012-11-25 | 2013-07-24 | 北京康华源科技发展有限公司 | 一种过滤检测技术装置 |
-
2012
- 2012-11-25 CN CN 201220626863 patent/CN203083994U/zh not_active Expired - Lifetime
-
2013
- 2013-11-22 WO PCT/CN2013/001433 patent/WO2014079152A1/zh active Application Filing
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014079152A1 (zh) * | 2012-11-25 | 2014-05-30 | 北京康华源科技发展有限公司 | 一种过滤检测装置及其应用 |
CN103869061A (zh) * | 2012-11-25 | 2014-06-18 | 常州博闻迪医药科技有限公司 | 一种过滤检测技术装置及其用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2014079152A1 (zh) | 2014-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mahler et al. | Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies | |
CN102798725B (zh) | 血清总IgE测定诊断试剂盒及制备和使用方法 | |
CN102628867A (zh) | 双抗体胶乳增强视黄醇结合蛋白检测试剂盒 | |
CN103869061A (zh) | 一种过滤检测技术装置及其用途 | |
CN102998467B (zh) | β人绒毛膜促性腺激素磁微粒化学发光免疫定量检测试剂盒及其制备方法 | |
CN201965131U (zh) | 一种甲型肝炎病毒IgM抗体快速检测试纸 | |
CN108663525A (zh) | 一种心梗心衰磁微粒微流控生物芯片、检测方法 | |
CN109870582A (zh) | 一种多靶标磁免疫化学发光微流控芯片检测平台及方法 | |
CN103048465B (zh) | 一种il-6微孔板式化学发光检测试剂盒及其制备方法 | |
CN107831163A (zh) | 一种甲状腺球蛋白的化学发光检测试剂盒及其制备方法 | |
CN109211868A (zh) | 一种快速定量检测myo的微流控荧光免疫芯片 | |
CN105372418A (zh) | 一种信号放大免疫检测方法 | |
CN109211867A (zh) | 一种快速定量检测bnp的微流控荧光免疫芯片 | |
CN102841210A (zh) | 一种视黄醇检测试剂盒及其制备方法 | |
CN109061207A (zh) | 一种用于心梗标志物检测的生物芯片、检测方法 | |
CA2944488A1 (en) | Immunoassay utilizing trapping conjugate | |
CN101021530A (zh) | 自动化通道分辨化学发光多组分免疫检测系统及分析方法 | |
CN203083994U (zh) | 一种过滤检测技术装置 | |
CN109211869A (zh) | 一种快速定量检测d-二聚体的微流控荧光免疫芯片 | |
CN201522494U (zh) | 双联法便潜血快速诊断层析试纸 | |
CN101344526A (zh) | 一种快速、精确的前列腺癌的检测试纸条及其制备和应用 | |
CN102600918B (zh) | 用于血液分析的微流体芯片及其使用方法 | |
CN102680621B (zh) | 一种化学发光检测技术及其用途 | |
WO2011014673A1 (en) | Automated lateral flow immunoassay cassette with improved flow properties | |
CN107843733A (zh) | 一种妊娠相关血浆蛋白a的磁微粒化学发光检测试剂盒及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGZHOU BIOWIN BIOPHARM CO., LTD. Free format text: FORMER OWNER: BEIJING CANNET TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20140609 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100085 HAIDIAN, BEIJING TO: 213144 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140609 Address after: 213144 No. 111-9, Dongfang Avenue, Changzhou, Jiangsu 401 Patentee after: CHANGZHOU BIOWIN BIOPHARM Co.,Ltd. Address before: 100085, C906, No. 9, 3rd Street, Beijing, Haidian District Patentee before: Beijing Kanghuayuan Technology Development Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 213012 3rd floor, No. 3 Building, California Science and Technology Port, 218 Fumin Road, Changzhou City, Jiangsu Province Patentee after: CHANGZHOU BOWENDI PHARMACEUTICAL CO.,LTD. Address before: 213144 401, 111-9 Dongfang Avenue, Changzhou City, Jiangsu Province Patentee before: CHANGZHOU BIOWIN BIOPHARM Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Filtering detection technique device and application thereof Effective date of registration: 20190418 Granted publication date: 20130724 Pledgee: Jiangsu Jiangnan Rural Commercial Bank Limited by Share Ltd. Pledgor: CHANGZHOU BOWENDI PHARMACEUTICAL CO.,LTD. Registration number: 2019990000341 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220420 Granted publication date: 20130724 Pledgee: Jiangsu Jiangnan Rural Commercial Bank Limited by Share Ltd. Pledgor: CHANGZHOU BOWENDI PHARMACEUTICAL CO.,LTD. Registration number: 2019990000341 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20130724 |